世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

北米の神経刺激装置市場予測 2019-2027年

NORTH AMERICA NEUROSTIMULATION DEVICE MARKET FORECAST 2019-2027

 

出版社 出版年月電子版価格 ページ数
Inkwood Research
インクウッドリサーチ
2019年1月US$1,250
シングルユーザライセンス(印刷不可PDF)
92

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

サマリー

この調査レポートは北米の神経刺激装置市場を分析・予測したInkwood Researchの市場調査報告書です。

Overview

KEY FINDINGS
A growing base of geriatric population triggering the incidence rates of target disorders will be attributed to the market growth in North America. The market is expected to propel at a CAGR of 9.73% during the forecasted years 2019-2027.

MARKET INSIGHTS

The United States neurostimulation device market is mainly driven owing to the increasing geriatric population which includes escalating cases of Alzheimer’s and Parkinson’s disease along with investments made by the government institutions in research & development activities for Alzheimer’s diseases. The US was the largest revenue contributor to this region in 2018 because of the increased use of neurostimulation devices for various diseases. Advances in technology and the availability of reimbursement by Medicare propel market growth in the country will be responsible for the market development in future.

COMPETITIVE INSIGHTS

Major market players in the region are Cogentix Medical Inc., St. Jude Medical Inc. (acquired by Abbott Laboratories), Aleva Neurotherapeutics SA, Boston Scientific Corporation, Helius Medical Technologies, The Magstim Company Limited, Cyberonics Inc., Neuronetics Inc., Depuy Synthes Companies, Ekso Bionics Holding Inc., Medtronic PLC, Dr. Langer Medical GmBH, Ectron Limited, Nevro Corp. and Hocoma AG.



目次

Table of Contents

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. SPINAL CORD STIMULATORS HOLDS THE LARGEST MARKET SHARE IN TERMS OF NEUROSTIMULATION SYSTEM
3.2.2. PAIN MANAGEMENT IS THE MAJORLY USED NEUROSTIMULATION APPLICATION
4. MARKET DYNAMICS
4.1. MARKET SCOPE & DEFINITION
4.2. MARKET DRIVERS
4.2.1. HIGH OCCURRENCE OF NEURO DISEASES
4.2.2. DEVELOPMENTS IN TECHNOLOGY
4.2.3. RISING DEMAND FOR MINIMALLY INVASIVE SURGERIES
4.2.4. HIGH MARKET POTENTIAL FOR SCS DEVICES IN NEUROSTIMULATION
4.2.5. INCREASING GERIATRIC POPULATION
4.2.6. FAVORABLE REIMBURSEMENT AND INSURANCE APPROVAL POLICIES
4.3. MARKET RESTRAINTS
4.3.1. HIGH PRICE OF NEUROMODULATION TREATMENT
4.3.2. SIDE EFFECTS OF ASSOCIATED NEUROSTIMULATION DEVICES
4.3.3. ANONYMOUS APPLIANCE OF SCS THERAPY
4.3.4. STRINGENT REGULATORY APPROVALS
4.4. MARKET OPPORTUNITIES
4.4.1. DEVELOPMENT OF INDICATION FOR SCS
4.4.2. INCREASING THE DEMAND FOR NEUROSTIMULATION DEVICES WITHSTANDING MRI SCANS
4.4.3. GROWING OCCURRENCE OF CHRONIC DISCOMFORT
4.5. MARKET CHALLENGES
4.5.1. OBTAINABILITY OF ALTERNATIVE THERAPY
4.5.2. SAFETY CONCERNS
5. MARKET BY SYSTEM
5.1. SPINAL CORD STIMULATORS (SCS)
5.2. DEEP BRAIN STIMULATORS (DBS)
5.3. SACRAL NERVE STIMULATORS (SNS)
5.4. VAGUS NERVE STIMULATORS (VNS)
5.5. GASTRIC ELECTRIC STIMULATOR
5.6. OTHER SYSTEM
6. MARKET BY APPLICATIONS
6.1. PAIN MANAGEMENT
6.2. EPILEPSY
6.3. ESSENTIAL TREMOR
6.4. URINARY AND FECAL INCONTINENCE
6.5. DEPRESSION
6.6. DYSTONIA
6.7. GASTROPARESIS
6.8. PARKINSON’S DISEASE
6.9. OTHER APPLICATIONS
7. KEY ANALYTICS
7.1. PORTER’S FIVE FORCE MODEL
7.1.1. THREAT OF NEW ENTRANTS
7.1.2. THREAT OF SUBSTITUTES
7.1.3. BARGAINING POWER OF SUPPLIERS
7.1.4. BARGAINING POWER OF BUYERS
7.1.5. THREAT OF RIVALRY
7.2. ESTIMATION ANALYSIS
7.2.1. INCREASING PREVALENCE OF MENTAL HEALTH PROBLEMS
7.2.2. RISING HEALTHCARE EXPENDITURE ACROSS THE GLOBE
7.2.3. RISING GERIATRIC POPULATION
7.3. VALUE CHAIN ANALYSIS
7.4. PESTLE ANALYSIS
7.5. OPPORTUNITY MATRIX
8. GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1. THE UNITED STATES
8.1.2. CANADA
9. COMPETITIVE LANDSCAPE
9.1. MARKET SHARE ANALYSIS
9.2. COMPANY PROFILES
9.2.1. ALEVA NEUROTHERAPEUTICS SA
9.2.1.1. OVERVIEW
9.2.1.2. PRODUCT PORTFOLIO
9.2.1.3. SCOT ANALYSIS
9.2.1.4. STRATEGIC INITIATIVES
9.2.2. BOSTON SCIENTIFIC CORPORATION
9.2.2.1. OVERVIEW
9.2.2.2. PRODUCT PORTFOLIO
9.2.2.3. SCOT ANALYSIS
9.2.2.4. STRATEGIC INITIATIVES
9.2.3. COGENTIX MEDICAL INC
9.2.3.1. OVERVIEW
9.2.3.2. PRODUCT PORTFOLIO
9.2.3.3. SCOT ANALYSIS
9.2.3.4. STRATEGIC INITIATIVES
9.2.4. CYBERONICS INC.
9.2.4.1. OVERVIEW
9.2.4.2. PRODUCT PORTFOLIO
9.2.4.3. SCOT ANALYSIS
9.2.4.4. STRATEGIC INITIATIVES
9.2.5. DEPUY SYNTHES COMPANIES
9.2.5.1. OVERVIEW
9.2.5.2. PRODUCT PORTFOLIO
9.2.5.3. SCOT ANALYSIS
9.2.5.4. STRATEGIC INITIATIVES
9.2.6. DR. LANGER MEDICAL GMBH
9.2.6.1. OVERVIEW
9.2.6.2. PRODUCT PORTFOLIO
9.2.6.3. SCOT ANALYSIS
9.2.6.4. STRATEGIC INITIATIVES
9.2.7. ECTRON LIMITED
9.2.7.1. OVERVIEW
9.2.7.2. PRODUCT PORTFOLIO
9.2.7.3. SCOT ANALYSIS
9.2.7.4. STRATEGIC INITIATIVE
9.2.8. EKSO BIONICS HOLDING INC.
9.2.8.1. OVERVIEW
9.2.8.2. PRODUCT PORTFOLIO
9.2.8.3. SCOT ANALYSIS
9.2.8.4. STRATEGIC INITIATIVE
9.2.9. HELIUS MEDICAL TECHNOLOGIES
9.2.9.1. OVERVIEW
9.2.9.2. PRODUCT PORTFOLIO
9.2.9.3. SCOT ANALYSIS
9.2.9.4. STRATEGIC INITIATIVE
9.2.10. HOCOMA AG
9.2.10.1. OVERVIEW
9.2.10.2. PRODUCT PORTFOLIO
9.2.10.3. SCOT ANALYSIS
9.2.10.4. STRATEGIC INITIATIVE
9.2.11. MEDTRONIC PLC
9.2.11.1. OVERVIEW
9.2.11.2. PRODUCT PORTFOLIO
9.2.11.3. SCOT ANALYSIS
9.2.11.4. STRATEGIC INITIATIVES
9.2.12. NEURONETICS INC.
9.2.12.1. OVERVIEW
9.2.12.2. PRODUCT PORTFOLIO
9.2.12.3. SCOT ANALYSIS
9.2.12.4. STRATEGIC INITIATIVES
9.2.13. NEVRO CORP
9.2.13.1. OVERVIEW
9.2.13.2. PRODUCT PORTFOLIO
9.2.13.3. SCOT ANALYSIS
9.2.13.4. STRATEGIC INITIATIVES
9.2.14. ST. JUDE MEDICAL INC. (ACQUIRED BY ABBOTT LABORATORIES)
9.2.14.1. OVERVIEW
9.2.14.2. PRODUCT PORTFOLIO
9.2.14.3. SCOT ANALYSIS
9.2.14.4. STRATEGIC INITIATIVE
9.2.15. THE MAGSTIM COMPANY LIMITED
9.2.15.1. COMPANY OVERVIEW
9.2.15.2. PRODUCT PORTFOLIO
9.2.15.3. SCOT ANALYSIS
9.2.15.4. STRATEGIC INITIATIVES


TABLE LIST
TABLE 1 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
TABLE 2 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY SYSTEM 2019-2027 ($ MILLION)
TABLE 3 NORTH AMERICA SPINAL CORD STIMULATORS MARKET 2019-2027 ($ MILLION)
TABLE 4 NORTH AMERICA DEEP BRAIN STIMULATORS MARKET 2019-2027 ($ MILLION)
TABLE 5 NORTH AMERICA SACRAL NERVE STIMULATORS MARKET 2019-2027 ($ MILLION)
TABLE 6 NORTH AMERICA VAGUS NERVE STIMULATORS MARKET 2019-2027 ($ MILLION)
TABLE 7 NORTH AMERICA GASTRIC ELECTRIC STIMULATOR MARKET 2019-2027 ($ MILLION)
TABLE 8 NORTH AMERICA OTHER SYSTEM MARKET 2019-2027 ($ MILLION)
TABLE 9 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY APPLICATIONS 2019-2027 ($ MILLION)
TABLE 10 NORTH AMERICA PAIN MANAGEMENT MARKET 2019-2027 ($ MILLION)
TABLE 11 NORTH AMERICA EPILEPSY MARKET 2019-2027 ($ MILLION)
TABLE 12 NORTH AMERICA ESSENTIAL TREMOR MARKET 2019-2027 ($ MILLION)
TABLE 13 NORTH AMERICA URINARY AND FECAL INCONTINENCE MARKET 2019-2027 ($ MILLION)
TABLE 14 NORTH AMERICA DEPRESSION MARKET 2019-2027 ($ MILLION)
TABLE 15 NORTH AMERICA DYSTONIA MARKET 2019-2027 ($ MILLION)
TABLE 16 NORTH AMERICA GASTROPARESIS MARKET 2019-2027 ($ MILLION)
TABLE 17 NORTH AMERICA PARKINSON’S DISEASE MARKET 2019-2027 ($ MILLION)
TABLE 18 NORTH AMERICA OTHER APPLICATIONS MARKET 2019-2027 ($ MILLION)
TABLE 19 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY GEOGRAPHY 2019-2027, (IN $ BILLION)
TABLE 20 CONDITION TREATED BY NEUROSTIMULATION DEVICES IN THE UNITED STATES
TABLE 21 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY COUNTRY 2019-2027 ($ MILLION)

FIGURES LIST
FIGURE 1 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 2 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET SHARE BY SYSTEM 2018 & 2027 (%)
FIGURE 3 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY SPINAL CORD STIMULATORS 2019-2027 ($ MILLION)
FIGURE 4 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY DEEP BRAIN STIMULATORS 2019-2027 ($ MILLION)
FIGURE 5 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY SACRAL NERVE STIMULATORS 2019-2027 ($ MILLION)
FIGURE 6 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY VAGUS NERVE STIMULATORS 2019-2027 ($ MILLION)
FIGURE 7 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY GASTRIC ELECTRIC STIMULATOR 2019-2027 ($ MILLION)
FIGURE 8 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY OTHER SYSTEM 2019-2027 ($ MILLION)
FIGURE 9 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET SHARE BY APPLICATIONS 2018 & 2027 (%)
FIGURE 10 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY PAIN MANAGEMENT 2019-2027 ($ MILLION)
FIGURE 11 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY EPILEPSY 2019-2027 ($ MILLION)
FIGURE 12 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY ESSENTIAL TREMOR 2019-2027 ($ MILLION)
FIGURE 13 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY URINARY AND FECAL INCONTINENCE 2019-2027 ($ MILLION)
FIGURE 14 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY DEPRESSION 2019-2027 ($ MILLION)
FIGURE 15 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY DYSTONIA 2019-2027 ($ MILLION)
FIGURE 16 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY GASTROPARESIS 2019-2027 ($ MILLION)
FIGURE 17 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY PARKINSON’S DISEASE 2019-2027 ($ MILLION)
FIGURE 18 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY OTHER APPLICATIONS 2019-2027 ($ MILLION)
FIGURE 19 PORTER’S FIVE FORCE MODEL
FIGURE 22 VALUE CHAIN OF NEUROSTIMULATION DRUGS
FIGURE 23 THE UNITED STATES NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 24 CANADA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 25 NEUROSTIMULATION DEVICE COMPANY MARKET SHARE 2018 (% )

List of Tables

TABLE LIST
TABLE 1 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
TABLE 2 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY SYSTEM 2019-2027 ($ MILLION)
TABLE 3 NORTH AMERICA SPINAL CORD STIMULATORS MARKET 2019-2027 ($ MILLION)
TABLE 4 NORTH AMERICA DEEP BRAIN STIMULATORS MARKET 2019-2027 ($ MILLION)
TABLE 5 NORTH AMERICA SACRAL NERVE STIMULATORS MARKET 2019-2027 ($ MILLION)
TABLE 6 NORTH AMERICA VAGUS NERVE STIMULATORS MARKET 2019-2027 ($ MILLION)
TABLE 7 NORTH AMERICA GASTRIC ELECTRIC STIMULATOR MARKET 2019-2027 ($ MILLION)
TABLE 8 NORTH AMERICA OTHER SYSTEM MARKET 2019-2027 ($ MILLION)
TABLE 9 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY APPLICATIONS 2019-2027 ($ MILLION)
TABLE 10 NORTH AMERICA PAIN MANAGEMENT MARKET 2019-2027 ($ MILLION)
TABLE 11 NORTH AMERICA EPILEPSY MARKET 2019-2027 ($ MILLION)
TABLE 12 NORTH AMERICA ESSENTIAL TREMOR MARKET 2019-2027 ($ MILLION)
TABLE 13 NORTH AMERICA URINARY AND FECAL INCONTINENCE MARKET 2019-2027 ($ MILLION)
TABLE 14 NORTH AMERICA DEPRESSION MARKET 2019-2027 ($ MILLION)
TABLE 15 NORTH AMERICA DYSTONIA MARKET 2019-2027 ($ MILLION)
TABLE 16 NORTH AMERICA GASTROPARESIS MARKET 2019-2027 ($ MILLION)
TABLE 17 NORTH AMERICA PARKINSON’S DISEASE MARKET 2019-2027 ($ MILLION)
TABLE 18 NORTH AMERICA OTHER APPLICATIONS MARKET 2019-2027 ($ MILLION)
TABLE 19 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY GEOGRAPHY 2019-2027, (IN $ BILLION)
TABLE 20 CONDITION TREATED BY NEUROSTIMULATION DEVICES IN THE UNITED STATES
TABLE 21 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY COUNTRY 2019-2027 ($ MILLION)

List of Figures

FIGURES LIST
FIGURE 1 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 2 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET SHARE BY SYSTEM 2018 & 2027 (%)
FIGURE 3 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY SPINAL CORD STIMULATORS 2019-2027 ($ MILLION)
FIGURE 4 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY DEEP BRAIN STIMULATORS 2019-2027 ($ MILLION)
FIGURE 5 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY SACRAL NERVE STIMULATORS 2019-2027 ($ MILLION)
FIGURE 6 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY VAGUS NERVE STIMULATORS 2019-2027 ($ MILLION)
FIGURE 7 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY GASTRIC ELECTRIC STIMULATOR 2019-2027 ($ MILLION)
FIGURE 8 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY OTHER SYSTEM 2019-2027 ($ MILLION)
FIGURE 9 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET SHARE BY APPLICATIONS 2018 & 2027 (%)
FIGURE 10 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY PAIN MANAGEMENT 2019-2027 ($ MILLION)
FIGURE 11 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY EPILEPSY 2019-2027 ($ MILLION)
FIGURE 12 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY ESSENTIAL TREMOR 2019-2027 ($ MILLION)
FIGURE 13 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY URINARY AND FECAL INCONTINENCE 2019-2027 ($ MILLION)
FIGURE 14 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY DEPRESSION 2019-2027 ($ MILLION)
FIGURE 15 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY DYSTONIA 2019-2027 ($ MILLION)
FIGURE 16 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY GASTROPARESIS 2019-2027 ($ MILLION)
FIGURE 17 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY PARKINSON’S DISEASE 2019-2027 ($ MILLION)
FIGURE 18 NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY OTHER APPLICATIONS 2019-2027 ($ MILLION)
FIGURE 19 PORTER’S FIVE FORCE MODEL
FIGURE 22 VALUE CHAIN OF NEUROSTIMULATION DRUGS
FIGURE 23 THE UNITED STATES NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 24 CANADA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)
FIGURE 25 NEUROSTIMULATION DEVICE COMPANY MARKET SHARE 2018 (% )

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る